IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 3914 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Antiretroviral drugs: Critical issues and recent advances

Desai Mira, Iyer Geetha, Dikshit R K

Year : 2012| Volume: 44| Issue : 3 | Page no: 288-298

   This article has been cited by
1 Development of Synthetic Approaches Towards HIV Integrase Strand Transfer Inhibitors (INSTIs)
Ashwini Amol Sawant, Surender Singh Jadav, Kiranmai Nayani, Prathama S. Mainkar
ChemistrySelect. 2022; 7(29)
[Pubmed]  [Google Scholar] [DOI]
2 Electroanalytical sensors for antiretroviral drugs determination in pharmaceutical and biological samples: A review
Kefilwe V. Mokwebo, Samantha F. Douman, Onyinyechi V. Uhuo, Kaylin C. Januarie, Marlon Oranzie, Emmanuel I. Iwuoha
Journal of Electroanalytical Chemistry. 2022; 920: 116621
[Pubmed]  [Google Scholar] [DOI]
3 Improvement in Bioavailability and Pharmacokinetic Characteristics of Efavirenz with Booster Dose of Ritonavir in PEGylated PAMAM G4 Dendrimers
Rohini Kharwade, Sachin More, Elizabeth Suresh, Amol Warokar, Nilesh Mahajan, Ujwala Mahajan
AAPS PharmSciTech. 2022; 23(6)
[Pubmed]  [Google Scholar] [DOI]
4 Application of Stem Cell Therapy During the Treatment of HIV/AIDS and Duchenne Muscular Dystrophy
Lorraine Chitena, Keletso Masisi, Kabo Masisi, Tebogo E. Kwape, Goabaone Gaobotse
Current Stem Cell Research & Therapy. 2022; 17(7): 633
[Pubmed]  [Google Scholar] [DOI]
Asian Journal of Pharmaceutical and Clinical Research. 2022; : 56
[Pubmed]  [Google Scholar] [DOI]
6 Estimation of maximum recommended therapeutic dose of anti-retroviral drugs using diversified sampling and varied descriptors
Roopshikha SAHU, Amisha YADAV, Abhigyan NATH
Minerva Biotechnology and Biomolecular Research. 2022; 33(4)
[Pubmed]  [Google Scholar] [DOI]
7 Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman, Gillian Dekkers, Arthur E. H. Bentlage, Marloes Grobben, Gestur Vidarsson, Rogier W. Sanders, Theo Verrips, Teunis B. H. Geijtenbeek, Raimond Heukers, Neeltje A. Kootstra, Steven W. de Taeye, Marit J. van Gils
Frontiers in Immunology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
8 Novel Antiretroviral Therapeutic Strategies for HIV
Rita F. Cunha, Sandra Simões, Manuela Carvalheiro, José M. Azevedo Pereira, Quirina Costa, Andreia Ascenso
Molecules. 2021; 26(17): 5305
[Pubmed]  [Google Scholar] [DOI]
9 Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
Nidhi Chauhan, Mira Desai, Samidh Shah, Asha Shah, Rajendra Gadhavi
Perspectives in Clinical Research. 2021; 12(1): 40
[Pubmed]  [Google Scholar] [DOI]
10 Applications of Nanoparticles for Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV) Treatment
Oluwafemi Obisesan, Lebogang Katata-Seru, Steven Mufamadi, Hazel Mufhandu
Journal of Biomedical Nanotechnology. 2021; 17(5): 793
[Pubmed]  [Google Scholar] [DOI]
11 A computational analysis of transcriptional profiles from CD8(+) T lymphocytes reveals potential mechanisms of HIV/AIDS control and progression
Sergey Ivanov, Dmitry Filimonov, Olga Tarasova
Computational and Structural Biotechnology Journal. 2021; 19: 2447
[Pubmed]  [Google Scholar] [DOI]
12 Use of long-acting injectable antiretroviral agents for Human Immunodeficiency Virus: A review
Olumuyiwa E Ariyo, Christopher E Jones
Journal of Clinical Virology. 2021; : 105032
[Pubmed]  [Google Scholar] [DOI]
13 HIV Capsid and Protease, New Targets of Melittin
Behzad Dehghani, Zahra Hasanshahi, Tayebeh Hashempour
International Journal of Peptide Research and Therapeutics. 2020; 26(4): 2057
[Pubmed]  [Google Scholar] [DOI]
14 The landscape of alternative splicing in HIV-1 infected CD4 T-cells
Seyoun Byun, Seonggyun Han, Yue Zheng, Vicente Planelles, Younghee Lee
BMC Medical Genomics. 2020; 13(S5)
[Pubmed]  [Google Scholar] [DOI]
15 An Overview of Antiretroviral Agents for Treating HIV Infection in Paediatric Population
Rita Melo, Agostinho Lemos, António J. Preto, Beatriz Bueschbell, Pedro Matos-Filipe, Carlos Barreto, José G. Almeida, Rúben D.M. Silva, João D.G. Correia, Irina S. Moreira
Current Medicinal Chemistry. 2020; 27(5): 760
[Pubmed]  [Google Scholar] [DOI]
16 Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents
Maria Assunta Chiacchio , Daniela Iannazzo , Roberto Romeo, Salvatore V. Giofrè , Laura Legnani
Current Medicinal Chemistry. 2020; 26(40): 7166
[Pubmed]  [Google Scholar] [DOI]
17 Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: a case–control study
Habtamu Mengist Meshesha, Zelalem Mehari Nigussie, Anemaw Asrat, Kebadnew Mulatu
BMJ Open. 2020; 10(7): e036223
[Pubmed]  [Google Scholar] [DOI]
18 Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?
V. Kalidasan, Kumitaa Theva Das
Frontiers in Microbiology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
Abhay S. Tirkey, Uppal Rashmi Kunkal
Journal of Evidence Based Medicine and Healthcare. 2019; 6(8): 617
[Pubmed]  [Google Scholar] [DOI]
20 Polymeric therapeutic delivery systems for the treatment of infectious diseases
Blessing A Aderibigbe
Therapeutic Delivery. 2017; 8(7): 557
[Pubmed]  [Google Scholar] [DOI]
21 Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
Cristina Tintori, Annalaura Brai, Maria Chiara Dasso Lang, Davide Deodato, Antonia Michela Greco, Bruno Mattia Bizzarri, Lorena Cascone, Alexandru Casian, Claudio Zamperini, Elena Dreassi, Emmanuele Crespan, Giovanni Maga, Guido Vanham, Elisa Ceresola, Filippo Canducci, Kevin K. Ariën, Maurizio Botta
Journal of Medicinal Chemistry. 2016; 59(6): 2747
[Pubmed]  [Google Scholar] [DOI]
22 Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview
Haiyong Jia, Diwakar Rai, Peng Zhan, Xuwang Chen, Xuemei Jiang, Xinyong Liu
Future Medicinal Chemistry. 2015; 7(5): 587
[Pubmed]  [Google Scholar] [DOI]
23 Evaluation of PD 404,182 as an Anti-HIV and Anti-Herpes Simplex Virus Microbicide
Ana M. Chamoun-Emanuelli, Michael Bobardt, Bernard Moncla, Marie K. Mankowski, Roger G. Ptak, Philippe Gallay, Zhilei Chen
Antimicrobial Agents and Chemotherapy. 2014; 58(2): 687
[Pubmed]  [Google Scholar] [DOI]
24 Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide
Chamoun-Emanuelli, A.M., Bobardt, M., Moncla, B., Gallay, P., Chen, Z.
Antimicrobial Agents and Chemotherapy. 2014; 58(2): 687-697
[Pubmed]  [Google Scholar]
25 Human immunodeficiency virus: The mutating virus challenging effective drug treatment
Lambert, L.
SA Pharmaceutical Journal. 2013; 80(10): 10-14
[Pubmed]  [Google Scholar]
26 Emerging need to use phytopharmaceuticals in the treatment of HIV
L. Chaitra Narayan,V. Ravishankar Rai,Supinya Tewtrakul
Journal of Pharmacy Research. 2013; 6(1): 218
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow